Chronic Kidney Diseases
Conditions
Brief summary
Despite its known prevalence, a recent study conducted with Prof. Cacoub (unpublished) on the national health insurance database showed that iron deficiency was a poorly diagnosed and poorly treated comorbidity. In patients with Chronic Kidney Disease but Non-Dialysis, the determination of Ferritinemia and Transferrin Saturation Factoris performed in only 30% and 10% of cases whereas they should be performed routinely in inflammatory situations and in case of anemia (HAS 2011, KDIGO 2012). The objective of this study is to obtain updated data on the prevalence of iron deficiency in France in patients with CKD-ND, applying the international recommendations and those of the French Health High Authority (determination of ferritinemia and Transferrin Saturation Factor).
Interventions
DIAGNOSTIC_TESTIron status testing
Iron status testing
Sponsors
VIFORFRANCE
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient, male or female, over 18 years of age; * Patient present at the hospital on the day of the study (traditional hospitalization, week hospital, day hospital, or in consultation with CKD-ND); * Diagnosis of CKD-ND (glomerular filtration rate (GFR) \> 15 mL/min/1.73 m²) * Patient with signed consent
Exclusion criteria
* Protected patient: major under guardianship, tutorship or other legal protection, deprived of liberty by judicial or administrative decision; * Pregnant or breastfeeding woman; * Patient with dialysis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Complete blood iron status | One day | ferritin |
Outcome results
None listed